A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis

Hepato-Gastroenterology

Volumn 57, Issue 102-103, 2010, Pages 1295-1299

  Huang, Qiu Lin ^a   Qian, Zhao Xin ^b   Li, Hao ^c  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Hunan Provincial People's Hospital   (China)

Author keywords

Acute pancreatitis; Disease severity; Early assessment; Urinary trypsinogen 2

Indexed keywords

TRYPSINOGEN; TRYPSINOGEN 2; TRYPSINOGEN ACTIVATION PEPTIDE; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SEVERITY INDEX; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; AGED; AREA UNDER CURVE; FEMALE; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; PANCREATITIS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TRYPSIN; TRYPSINOGEN;

EID: 79251550740     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand JA, Skerrett SJ, Stapleton RD, Ware LB, Waldmann CS: Management of the critically ill patient with severe acute pancreatitis. Crit Care Med. 2004; 32(12):2524-2536.
2. Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, Matsumoto I, Fujita T, Sakai T, Ajiki T, Fujino Y, Kuroda Y: Treatment strategy against infection: clinical outcome of continuous regional arterial infusion, enteral nutrition, and surgery in severe acute pancreatitis. J Gastroenterol. 2007; 42(8):681-689.
3. Beger HG, Rau BM: Severe acute pancreatitis: Clinical course and management. World J Gastroenterol. 2007; 13(38):5043-5051.
4. Brivet FG, Emilie D, Galanaud P: Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999; 27:749-755.
5. Sandberg AA, Borgström A: Early prediction of severity in acute pancreatitis. Is this possible? JOP. 2002; 3(5):116-125.
6. Messmann H, VogtW, Holstege A, Lock G, Heinisch A, von Furstenberg A et al: Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 1997; 40:80-85.
7. Jiang CF, Shiau YC, Ng KW, Tan SW: Serum interleukin-6, tumor necrosis factor alpha and C-reactive protein in early prediction of severity of acute pancreatitis. J Chin Med Assoc. 2004; 67(9):442-446.
8. Mayer JM, Raraty M, Slavin J, Kemppainen E, Fitzpatrick J, Hietaranta A, Puolakkainen P, Beger HG, Neoptolemos JP: Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.Br J Surg. 2002; 89(2):163-171.
9. Toh SKC, Phillips S, Johnson CD: A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England. Gut. 2000; 46:239-243.
10. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FK: Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974; 139:69-81.
11. Leese T, Shaw D: Comparison of three Glasgow multifactor prognostic scoring systems in acute pancreatitis. Br J Surg. 1988; 75:460-462.
12. Itkonen O, Koivunen E, Hurme M, Alfthan H, Schröder T, Stenman UH: Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990; 115:712-718.
13. Lempinen M, Kylänpää-Bäck ML, Stenman UH, Puolakkainen P, Haapiainen R, Finne P, Korvuo A, Kemppainen E: Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine. CUn Chem. 2001; 47(12):2103-2107.
14. Papachristou GI, Whitcomb DC: Predictors of severity and necrosis in acute pancreatitis. Gastroenterol Clin North Am. 2004; 33(4):871-890.
15. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet. 2000; 355(9219):1955-1960.
16. Liu ZS, Jiang CQ, Qian Q, Sun Q, Fan LF, Ai ZL: Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide. Hepatobiliary Pancreat Dis Int. 2002; 1(2):285-289.
17. Johnson CD, Lempinen M, Imrie CW, Puolakkainen P, Kemppainen E, Carter R, McKay C: Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br J Surg. 2004; 91(8):1027-1033.
18. Gürleyik G, Emir S, Kiliçoglu G, Arman A, Saglam A: Computed tomography severity index, APACHE II score, and serum CRP concentration for predicting the severity of acute pancreatitis. JOP. 2005; 6(6):562-567.
19. Simchuk EJ, Traverso LW, Nukui Y, Kozarek RA: Computed tomography severity index is a predictor of outcomes for severe pancreatitis. Am J Surg. 2000; 179(5):352-355.
20. rd: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993; 128(5):586-590.
21. Grinblatt JA: Measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med. 1997; 337(19):1394-1355.
22. Kylänpää-Bäck M, Kemppainen E, Puolakkainen P, Hedström J, Haapiainen R, Perhoniemi V, Kivilaakso E, Korvuo A, Stenman U: Reliable screening for acute pancreatitis with rapid urine trypsinogen-2 test strip. Br J Surg. 2000; 87(1):49-52.
23. Hurley PR, Cook A, Jehanli A, Austen BM, Hermon-Taylor J: Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods. 1988; 111(2):195-203.
24. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH: Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990; 174(2):331-336.
25. Balthazar EJ: Staging of acute pancreatitis. Radiol Clin North Am. 2002; 40(6):1199-1209.
26. Triantopoulou C, Lytras D, Maniatis P, Chrysovergis D, Manes K, Siafas I, Papailiou J, Dervenis C: Computed tomography versus Acute Physiology and Chronic Health Evaluation II score in predicting severity of acute pancreatitis: a prospective, comparative study with statistical evaluation. Pancreas. 2007; 35(3):238-242.
27. Alhajeri A, Erwin S: Acute pancreatitis: value and impact of CT severity index. Abdom Imaging. 2008; 33(1):18-20.
28. Hedström J, Korvuo A, Kenkimäki P, Tikanoja S, Haapiainen R, Kivilaakso E, Stenman UH: Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet. 1996; 347(9003):729-730.
29. Chen YT, Chen CC, Wang SS, Chang FY, Lee SD: Rapid urinary trypsinogen-2 test strip in the diagnosis of acute pancreatitis. Pancreas. 2005; 30(3):243-247.
30. Kemppainen E, Hietaranta A, Puolakkainen P, Hedström J, Haapiainen R, Stenman UH: Time course profile of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin in patients with acute pancreatitis. Scand J Gastroenterol. 2000; 35(11):1216-1220.